Back to News
Market Impact: 0.3
Precision BioSciences, Inc. Reports Third Quarter 2026 Financial Results
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Precision BioSciences reported a third-quarter 2026 net loss of $7.6 million, or $0.28 per basic and diluted share, compared with a $21.8 million net loss, or $1.84 per share, in the comparison period. The excerpt indicates a narrower loss but provides no further results or outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
DTIL0.35
More News
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- Disney Plans Thousands of Layoffs Companywide
- AMD rides data center riches to ‘largest and most profitable’ quarter in history
- ‘Lawyer up’: Democrats take the House, and warn Trump’s family businesses are first in line for subpoenas